Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.
Browse Other Projects on Experiment
Related Projects
Developing a low-cost, rapid diagnostic for urogenital Schistosomiasis infection
We are developing a frugal diagnostic for urogenital schistosomiasis, a neglected tropical disease that...
Can we biologically extend the range of human vision into the near infrared?
We have developed a protocol to augment human sight to see into the near infrared range through human formation...
NoAAC Longitudinal Registry of Treatment Outcomes in iSGS
Idiopathic subglottic stenosis (iSGS) is a rare and life-threatening disease involving airway obstruction...